B

Halozyme Therapeutics, Inc. HALO

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$95.01$97.96
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Revenue 45.03% 41.15% 39.12% 37.55% 31.19%
Total Other Revenue -- -- -- -- --
Total Revenue 45.03% 41.15% 39.12% 37.55% 31.19%
Cost of Revenue 65.04% 53.33% 38.40% 30.11% 5.00%
Gross Profit 39.68% 37.75% 39.34% 39.84% 40.56%
SG&A Expenses 37.22% 33.93% 29.31% 25.31% 15.11%
Depreciation & Amortization 57.52% 40.98% 24.44% 7.90% 0.00%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 54.50% 45.01% 33.35% 25.11% 7.46%
Operating Income 38.53% 38.35% 43.82% 48.02% 54.59%
Income Before Tax -12.19% -15.72% -16.79% -16.20% 55.37%
Income Tax Expenses 12.73% 25.88% 29.24% 32.68% 71.69%
Earnings from Continuing Operations -18.48% -25.78% -28.13% -28.64% 51.73%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -18.48% -25.78% -28.13% -28.64% 51.73%
EBIT 38.53% 38.35% 43.82% 48.02% 54.59%
EBITDA 40.22% 38.50% 41.56% 43.18% 47.07%
EPS Basic -14.29% -21.44% -24.20% -25.45% 59.02%
Normalized Basic EPS 41.80% 43.83% 51.30% 57.19% 63.55%
EPS Diluted -17.36% -23.45% -26.19% -27.54% 57.13%
Normalized Diluted EPS 40.56% 43.30% 51.01% 56.91% 61.90%
Average Basic Shares Outstanding -4.36% -5.53% -5.80% -5.49% -4.27%
Average Diluted Shares Outstanding -3.53% -5.06% -5.43% -5.11% -3.31%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --